KINETIC, ENZYME INDUCTION, AH-RECEPTOR In vitro metabolism of 2,2',3,4',5,5',6- heptachlorobiphenyl(CB187) with liver microsomes of rats, hamsters and guinea pigs

ORGANOHALOGEN COMPOUNDS – Volume 66 (2004) 2882 Introduction PCB congeners possess extremely high lipophilicity and biological stability, and as a result they are not easily eliminated from the body once ingested. In particular, not only 2,4,5-trichlorosubstituted but also 6 or more chlorine-substituted PCBs such as 2,2’,3’,4,4’,5-hexa-chlorobiphenyl (hexaCB) (CB138), 2,2’,4,4’,5,5’-hexaCB (CB153), 2,2’,3,4,4’,5,5’-heptachloro-biphenyl (heptaCB) (CB180) and 2,2’,3,4’,5,5’,6-heptaCB (CB187) have been detected in blood and adipose tissues of mammals and human mother’s milk at higher concentration. In addition, the 4-hydroxy (OH)-metabolite of CB187 has been reported to be present in human blood at the highest concentration of that derived from other PCB congeners. Although CB187, a tri-ortho-PCB, is one of the minor component in the commercial PCB preparations such as Clophen, Aroclor and Kanechlor, the toxic equivalency factor (TEF) which is used for dioxin-like PCB congeners including coplanar-PCBs and mono-ortho-PCBs to assess the potency of the toxicity has not been set up for diand tri-ortho-PCB congeners. These facts indicate that 4-OH-PCB187 become more persistent and more important toxicologically than the parent CB187. However, there is little report about biotransformation in vivo or in vitro of CB187 in animals. Therefore, we examined CB187 metabolism by liver microsomes of rats, hamsters and guinea pigs.